Compare CORT & SCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | SCI |
|---|---|---|
| Founded | 1998 | 1962 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 11.6B |
| IPO Year | 2001 | 1994 |
| Metric | CORT | SCI |
|---|---|---|
| Price | $111.91 | $83.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $96.50 | ★ $98.00 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | N/A | ★ 7.65 |
| EPS | 0.09 | ★ 1.87 |
| Revenue | $761,407,000.00 | ★ $4,309,234,000.00 |
| Revenue This Year | $26.08 | $4.03 |
| Revenue Next Year | $26.98 | $3.73 |
| P/E Ratio | $1,267.14 | ★ $44.40 |
| Revenue Growth | ★ 12.79 | 2.93 |
| 52 Week Low | $28.66 | $68.41 |
| 52 Week High | $122.21 | $90.99 |
| Indicator | CORT | SCI |
|---|---|---|
| Relative Strength Index (RSI) | 65.59 | 58.65 |
| Support Level | $76.41 | $76.47 |
| Resistance Level | $122.21 | $85.09 |
| Average True Range (ATR) | 5.21 | 2.49 |
| MACD | 0.55 | -0.17 |
| Stochastic Oscillator | 72.40 | 49.15 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, it provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. The company derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.